Temsirolimus and haemoglobin decreased 
Temsirolimus and haemoglobin decreased Patient Reports February 10, 2010
Temsirolimus Side Effects Report #5880048-0
Temsirolimus side effect was reported by a Physician from CHINA on Sept 09, 2008. Male patient, weighting 149.9 lb, was diagnosed with renal cell carcinoma and was treated with Temsirolimus. After drug was administered, patient experienced the following side effects: agitation, blood lactate dehydrogenase increased, depressed level of consciousness, haemoglobin decreased, platelet count decreased, pneumonia
, respiratory failure. Temsirolimus dosage: unknown. Patient died on 08/14/2008.Temsirolimus Side Effects Report #6113044-9
Temsirolimus side effect was reported by a Physician from CHINA on Mar 11, 2009. Female patient, weighting 154.3 lb, was diagnosed with renal cell carcinoma and was treated with Temsirolimus. After drug was administered, patient experienced the following side effects: alpha haemolytic streptococcal infection, blood glucose increased, blood pressure decreased, blood pressure increased, blood sodium decreased, haemoglobin decreased, lung infection, neisseria infection, neoplasm progression. Temsirolimus dosage: unknown. Patient was hospitalized. Patient died on 01/18/2009.
Temsirolimus Side Effects Report #5684991-7
Temsirolimus side effect was reported by a Physician from UNITED STATES on Mar 18, 2008. Male patient, weighting 91.49 lb, was diagnosed with neuroblastoma
, prophylaxis and was treated with Temsirolimus. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, haemoglobin decreased, headache , hypotension, platelet count decreased, sepsis syndrome. Temsirolimus dosage: unknown. During the same period patient was treated with LUGOL. Patient was hospitalized. Patient recovered.Temsirolimus Side Effects Report #5454618-8
Temsirolimus side effect was reported by a Physician from UNITED STATES on Sept 07, 2007. Male patient, 68 years of age, was diagnosed with multiple myeloma
, nausea and was treated with Temsirolimus. After drug was administered, patient experienced the following side effects: haematoma, haemoglobin decreased, platelet count decreased. Temsirolimus dosage: 15 MG/M2 WEEKLY. During the same period patient was treated with ATORVASTATIN CALCIUM, ENOXAPARIN, OXYCODONE, ACETAMINOPHEN, PREDNISONE, VALACYCLOVIR, ONDANSETRON. Patient was hospitalized. Patient recovered.Temsirolimus Side Effects Report #5717930-0
Temsirolimus side effect was reported by a Physician from UNITED STATES on Apr 21, 2008. Male patient, weighting 229.3 lb, was diagnosed with multiple myeloma
and was treated with Temsirolimus. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, acute respiratory failure, blood creatinine increased, haematocrit decreased, haemoglobin decreased, hypotension, international normalised ratio increased, multi-organ failure, myocardial infarction. Temsirolimus dosage: unknown. During the same period patient was treated with NEURONTIN, ADVAIR HFA, OXYCODONE, AMOXICILLIN, VALTREX, BORTEZOMIB, METOPROLOL TARTRATE. Patient was hospitalized. Patient died on 04/11/2008.Temsirolimus Side Effects Report #5383894-5
Temsirolimus side effect was reported by a Physician from CANADA on July 04, 2007. Male patient, weighting 183.0 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Temsirolimus. After drug was administered, patient experienced the following side effects: cardiac arrest
, haematemesis, haemoglobin decreased, nausea , syncope, upper gastrointestinal haemorrhage. Temsirolimus dosage: 25 MG QWK (ONLY ONE DOSE WAS GIVEN). Patient was hospitalized. Patient died on 06/03/2007.Temsirolimus Side Effects Report #6045050-7
Temsirolimus side effect was reported by a Physician from UNITED STATES on Jan 09, 2009. Female patient, 73 years of age, weighting 141.1 lb, was diagnosed with malignant peritoneal neoplasm, urinary tract infection
and was treated with Temsirolimus. After drug was administered, patient experienced the following side effects: dehydration, haemoglobin decreased, hypokalaemia, lung infiltration, pneumonitis, pyrexia. Temsirolimus dosage: unknown. During the same period patient was treated with COUMADIN, LASIX, COMPAZINE, ATARAX, MACROBID, ZOFRAN. Patient was hospitalized. Patient recovered.Temsirolimus Side Effects Report #6047145-0
Temsirolimus side effect was reported by a Physician from UNITED STATES on Jan 09, 2009. Female patient, 73 years of age, weighting 141.1 lb, was diagnosed with malignant peritoneal neoplasm, urinary tract infection
and was treated with Temsirolimus. After drug was administered, patient experienced the following side effects: asthenia, blood pressure systolic increased, dehydration, ear pain, fatigue, haematocrit decreased, haemoglobin decreased, hypokalaemia, lung infiltration. Temsirolimus dosage: unknown. During the same period patient was treated with COUMADIN, LASIX, COMPAZINE, ATARAX, MACROBID, ZOFRAN. Patient was hospitalized. Patient recovered.Temsirolimus Side Effects Report #5129924-7
Temsirolimus side effect was reported by a Physician from UKRAINE on Sept 21, 2006. Female patient, 76 years of age, was diagnosed with breast cancer
and was treated with Temsirolimus. After drug was administered, patient experienced the following side effects: band neutrophil percentage increased, cardiac disorder, fatigue, haemoglobin decreased, infection , lobar pneumonia, monocyte percentage decreased, poisoning , sputum discoloured. Temsirolimus dosage: 30 MG D1-D5 ORAL. During the same period patient was treated with LETROZOLE, LISINOPRIL AND HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.Temsirolimus Side Effects Report #5129924-7
Temsirolimus side effect was reported by a Consumer or non-health professional from UKRAINE on Sept 21, 2006. Female patient, 76 years of age, was diagnosed with breast cancer
and was treated with Temsirolimus. After drug was administered, patient experienced the following side effects: band neutrophil percentage increased, cardiac disorder, fatigue, haemoglobin decreased, infection , lobar pneumonia, monocyte percentage decreased, poisoning , sputum discoloured. Temsirolimus dosage: 30 MG D1-D5 ORAL. During the same period patient was treated with LETROZOLE, LISINOPRIL. Patient was hospitalized. Patient recovered.